Sophiris Bio Inc. | Key People and Executives
Randall E. Woods
President, Chief Executive Officer & Director
Allison J. Hulme
COO, Director & Head-Research & Development
Jim L. Heppell
Independent Director
Gerald T. Proehl
Independent Director
John Geltosky
Independent Director
Randall E. Woods
President, Chief Executive Officer & Director
Allison J. Hulme
COO, Director & Head-Research & Development
Peter T. Slover
Chief Financial Officer
Jim L. Heppell
Independent Director
Gerald T. Proehl
Independent Director
John Geltosky
Independent Director
| Address |
1258 Prospect Street
La Jolla California 92037
United States
|
|
Employees
|
- |
| Website |
http://www.sophirisbio.com |
| Updated |
07/08/2019 |
| Sophiris Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products for the treatment of urological diseases. It is currently developing PRX302 as a treatment for the symptoms of benign prostatic hyperplasia which is a non cancerous enlargement of the prostate gland that causes a restriction in urine flow from the urethra resulting in lower urinary tract symptoms. The company was founded by James L. |
